review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Henrik Hagberg | Q37370618 |
Klas Blomgren | Q38547060 | ||
P433 | issue | 3 | |
P921 | main subject | mitochondrion | Q39572 |
hypoxia | Q105688 | ||
P304 | page(s) | 388-397 | |
P577 | publication date | 2005-11-09 | |
P1433 | published in | Free Radical Biology and Medicine | Q5500023 |
P1476 | title | Free radicals, mitochondria, and hypoxia-ischemia in the developing brain | |
P478 | volume | 40 |
Q36569112 | An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations |
Q37989302 | Antioxidant therapies: a potential role in perinatal medicine. |
Q48397448 | Apoptosis-inducing factor is a major contributor to neuronal loss induced by neonatal cerebral hypoxia-ischemia. |
Q34179670 | Apoptotic cell death correlates with ROS overproduction and early cytokine expression after hypoxia-ischemia in fetal lambs |
Q36907496 | Apoptotic mechanisms in the immature brain: involvement of mitochondria |
Q34272422 | Association of NOS3 gene variants and clinical contributors of hypoxic-ischemic encephalopathy |
Q36464580 | Bax inhibiting peptide reduces apoptosis in neonatal rat hypoxic-ischemic brain damage |
Q30616090 | Brain development in rodents and humans: Identifying benchmarks of maturation and vulnerability to injury across species |
Q48603535 | Cerebral white matter oxidation and nitrosylation in young rodents with kaolin-induced hydrocephalus |
Q33805700 | Chronic fetal hypoxia produces selective brain injury associated with altered nitric oxide synthases |
Q36501670 | Critical role of neuronal pentraxin 1 in mitochondria-mediated hypoxic-ischemic neuronal injury |
Q90271627 | Current paradigms and new perspectives on fetal hypoxia: implications for fetal brain development in late gestation |
Q40078357 | Deferoxamine prevents cerebral glutathione and vitamin E depletions in asphyxiated neonatal rats: role of body temperature. |
Q38109493 | Developmental neurotoxicity of engineered nanomaterials: identifying research needs to support human health risk assessment |
Q28568993 | Docosahexaenoic acid enhances iron uptake by modulating iron transporters and accelerates apoptotic death in PC12 cells |
Q46798967 | Docosahexaenoic acid-dependent iron accumulation in oligodendroglia cells protects from hydrogen peroxide-induced damage |
Q34363951 | Docosahexaenoic acid: brain accretion and roles in neuroprotection after brain hypoxia and ischemia |
Q36925915 | Does Caspase-6 Have a Role in Perinatal Brain Injury? |
Q37196489 | Effect of ischemic preconditioning on antioxidant status in the gerbil hippocampal CA1 region after transient forebrain ischemia |
Q93035979 | Effects of PM2.5 and gases exposure during prenatal and early-life on autism-like phenotypes in male rat offspring |
Q35558807 | Endonuclease VIII-like 3 (Neil3) DNA glycosylase promotes neurogenesis induced by hypoxia-ischemia |
Q37577306 | Endoplasmic reticulum stress, inflammation, and perinatal brain damage |
Q36912624 | Enhanced hippocampus-dependent memory and reduced anxiety in mice over-expressing human catalase in mitochondria |
Q27006548 | Environmental risk factors for multiple sclerosis: a review with a focus on molecular mechanisms |
Q44100590 | Environmental tobacco smoke induces oxidative stress in distinct brain regions of infant mice |
Q33665291 | Ethyl pyruvate protects against hypoxic-ischemic brain injury via anti-cell death and anti-inflammatory mechanisms |
Q90216631 | Exercise During Adolescence Attenuated Depressive-Like Behaviors and Hippocampal Mitochondrial Dysfunction Following Early Life Stress in Adult Male Rats |
Q33862628 | Exploring uncoupling proteins and antioxidant mechanisms under acute cold exposure in brains of fish |
Q46722035 | Extracellular amino acids and lipid peroxidation products in periventricular white matter during and after cerebral ischemia in preterm fetal sheep |
Q42150350 | Failure to complete apoptosis following neonatal hypoxia-ischemia manifests as "continuum" phenotype of cell death and occurs with multiple manifestations of mitochondrial dysfunction in rodent forebrain |
Q35151967 | Genetic deletion of neuronal pentraxin 1 expression prevents brain injury in a neonatal mouse model of cerebral hypoxia-ischemia |
Q53423640 | Hemin protects against oxygen-glucose deprivation-induced apoptosis activation via neuroglobin in SH-SY5Y cells. |
Q38075513 | Hypothermia and xenon: novel noble guardians in hypoxic-ischemic encephalopathy? |
Q34202384 | Hypoxic preconditioning protection is eliminated in HIF-1α knockout mice subjected to neonatal hypoxia-ischemia |
Q33770270 | Hypoxic-ischemic encephalopathy in the term infant |
Q23914179 | Impact of neonatal asphyxia and hind limb immobilization on musculoskeletal tissues and S1 map organization: implications for cerebral palsy |
Q35938560 | Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy |
Q44435984 | Inhaled nitric oxide protects males but not females from neonatal mouse hypoxia-ischemia brain injury |
Q46259285 | Injury and repair in the immature brain |
Q38883176 | Intratracheal transplantation of mesenchymal stem cells simultaneously attenuates both lung and brain injuries in hyperoxic newborn rats |
Q28571963 | Ischemia enhances activation by Ca2+ and redox modification of ryanodine receptor channels from rat brain cortex |
Q48567539 | Lipopolysaccharide preconditioning reduces neuroinflammation against hypoxic ischemia and provides long-term outcome of neuroprotection in neonatal rat. |
Q42348594 | Loss of apoptosis-inducing factor results in cell-type-specific neurogenesis defects |
Q48110948 | Maternal Oxytocin Administration Before Birth Influences the Effects of Birth Anoxia on the Neonatal Rat Brain |
Q47333023 | Maternal and Cord Blood Manganese Concentrations and Early Childhood Neurodevelopment among Residents near a Mining-Impacted Superfund Site |
Q39138506 | Maternal creatine supplementation during pregnancy prevents acute and long-term deficits in skeletal muscle after birth asphyxia: a study of structure and function of hind limb muscle in the spiny mouse. |
Q37165162 | Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease |
Q64054843 | Mechanism and Treatment Related to Oxidative Stress in Neonatal Hypoxic-Ischemic Encephalopathy |
Q37986198 | Mitochondria and perinatal brain injury. |
Q47910121 | Mitochondrial LON protease-dependent degradation of cytochrome c oxidase subunits under hypoxia and myocardial ischemia |
Q33291145 | Mitochondrial cell death control in familial Parkinson disease |
Q47229517 | Mitochondrial dynamics, mitophagy and biogenesis in neonatal hypoxic-ischaemic brain injury. |
Q46571252 | Mitochondrial dysfunction bridges negative affective disorders and cardiomyopathy in socially isolated rats: Pros and cons of fluoxetine. |
Q34988707 | Mitochondrial mechanisms of cell death and neuroprotection in pediatric ischemic and traumatic brain injury |
Q99635112 | Molecular and Therapeutic Aspects of Hyperbaric Oxygen Therapy in Neurological Conditions |
Q37655647 | Molecular chaperones and hypoxic-ischemic encephalopathy |
Q33570328 | Necrostatin-1 attenuates mitochondrial dysfunction in neurons and astrocytes following neonatal hypoxia-ischemia |
Q30847961 | Neonatal Hypoxia Ischaemia: Mechanisms, Models, and Therapeutic Challenges |
Q34954213 | Neuroinflammation and neuroimmune dysregulation after acute hypoxic-ischemic injury of developing brain |
Q46921241 | Neuroprotective effect of diphenyl diselenide in a experimental stroke model: maintenance of redox system in mitochondria of brain regions |
Q26999039 | Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia |
Q33772042 | Neuroprotective therapies after perinatal hypoxic-ischemic brain injury |
Q38089709 | Nitric oxide signaling in the brain: a new target for inhaled nitric oxide? |
Q52147240 | No improvement of neuronal metabolism in the reperfusion phase with melatonin treatment after hypoxic-ischemic brain injury in the neonatal rat. |
Q34957102 | Overweight worsens apoptosis, neuroinflammation and blood-brain barrier damage after hypoxic ischemia in neonatal brain through JNK hyperactivation. |
Q42650888 | Oxidative stress and endoplasmic reticulum (ER) stress in the development of neonatal hypoxic-ischaemic brain injury |
Q38957623 | Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin. |
Q36725308 | Oxidative stress and the antioxidant enzyme system in the developing brain |
Q43271959 | Oxygen glucose deprivation model of cerebral stroke in PC-12 cells: glucose as a limiting factor |
Q37293099 | Oxygen in health and disease: regulation of oxygen homeostasis--clinical implications |
Q47649858 | Partition of metals in the maternal/fetal unit and lead-associated decreases of fetal iron and manganese: an observational biomonitoring approach |
Q30790294 | Pathophysiology of glia in perinatal white matter injury |
Q57929840 | Perinatal Hypoxic-Ischemic Encephalopathy and Neuroprotective Peptide Therapies: A Case for Cationic Arginine-Rich Peptides (CARPs) |
Q38538932 | Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology |
Q28482353 | Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects |
Q90388088 | Photobiomodulation Therapy Attenuates Hypoxic-Ischemic Injury in a Neonatal Rat Model |
Q26751830 | Plasticity in the Neonatal Brain following Hypoxic-Ischaemic Injury |
Q37348559 | Postischemic oxidative stress promotes mitochondrial metabolic failure in neurons and astrocytes |
Q28572255 | Postnatal developmental regulation of Bcl-2 family proteins in brain mitochondria |
Q34249394 | Prenatal hypoxic-ischemic insult changes the distribution and number of NADPH-diaphorase cells in the cerebellum |
Q47631553 | Pressure passivity of cerebral mitochondrial metabolism is associated with poor outcome following perinatal hypoxic ischemic brain injury. |
Q35994637 | Programmed Necrosis: A Prominent Mechanism of Cell Death following Neonatal Brain Injury |
Q34292332 | Protective effect of tanshinone IIA on the brain and its therapeutic time window in rat models of cerebral ischemia-reperfusion |
Q91724541 | Quantitative Proteomics of Presynaptic Mitochondria Reveal an Overexpression and Biological Relevance of Neuronal MitoNEET in Postnatal Brain Development |
Q36517190 | Quantitative imaging of mitochondrial and cytosolic free zinc levels in an in vitro model of ischemia/reperfusion. |
Q37304709 | Rapidly increased neuronal mitochondrial biogenesis after hypoxic-ischemic brain injury |
Q34437354 | Regional characterization of energy metabolism in the brain of normal and MPTP-intoxicated mice using new markers of glucose and phosphate transport |
Q89359675 | Regionally Impaired Redox Homeostasis in the Brain of Rats Subjected to Global Perinatal Asphyxia: Sustained Effect up to 14 Postnatal Days |
Q37694778 | Resveratrol post-treatment protects against neonatal brain injury after hypoxia-ischemia |
Q61813193 | Retinal Neuron Is More Sensitive to Blue Light-Induced Damage than Glia Cell Due to DNA Double-Strand Breaks |
Q37103110 | Role of Mitochondria in Neonatal Hypoxic-Ischemic Brain Injury |
Q28083288 | Role of mitochondria in apoptotic and necroptotic cell death in the developing brain |
Q31148061 | Sex differences in mitochondrial biogenesis determine neuronal death and survival in response to oxygen glucose deprivation and reoxygenation |
Q39015326 | Sex-dependent consequences of neonatal brain hypoxia-ischemia in the rat. |
Q36926979 | Sex-dependent mitochondrial respiratory impairment and oxidative stress in a rat model of neonatal hypoxic-ischemic encephalopathy |
Q41587922 | Sex-dependent mitophagy and neuronal death following rat neonatal hypoxia-ischemia |
Q47895402 | Sexually Dimorphic Outcomes after Neonatal Stroke and Hypoxia-Ischemia |
Q36682284 | Sodium pyruvate reduces hypoxic-ischemic injury to neonatal rat brain |
Q46946957 | Stimulation of NOX2 in isolated hearts reversibly sensitizes RyR2 channels to activation by cytoplasmic calcium |
Q35576397 | Striatal neuroprotection from neonatal hypoxia-ischemia in piglets by antioxidant treatment with EUK-134 or edaravone |
Q37732938 | Tetrahydrocurcumin reduces oxidative stress-induced apoptosis via the mitochondrial apoptotic pathway by modulating autophagy in rats after traumatic brain injury |
Q58790366 | The Hippocampal Neuro-Glio-Vascular Network: Metabolic Vulnerability and Potential Neurogenic Regeneration in Disease |
Q41501801 | The NADPH oxidase NOX2 as a novel biomarker for suicidality: evidence from human post mortem brain samples |
Q48905321 | The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia |
Q38924641 | The mGluR5 positive allosteric modulator CDPPB inhibits SO₂-induced protein radical formation and mitochondrial dysfunction through activation of Akt in mouse hippocampal HT22 cells |
Q39442839 | The role of microglia in multiple sclerosis. |
Q34042991 | Timing of appearance of late oligodendrocyte progenitors coincides with enhanced susceptibility of preterm rabbit cerebral white matter to hypoxia-ischemia |
Q37503349 | Toxicity biomarkers among US children compared to a similar cohort in France: a blinded study measuring urinary porphyrins |
Q92085261 | Treatment With Tetrahydrobiopterin Improves White Matter Maturation in a Mouse Model for Prenatal Hypoxia in Congenital Heart Disease |
Q37131984 | Treatment advances in neonatal neuroprotection and neurointensive care |
Q36742901 | Two new "protected" oxyphors for biological oximetry: properties and application in tumor imaging |
Q38248001 | Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury |
Q42198882 | Vitamin K prevents oxidative cell death by inhibiting activation of 12-lipoxygenase in developing oligodendrocytes |
Q36747748 | eIF2B and oligodendrocyte survival: where nature and nurture meet in bipolar disorder and schizophrenia? |
Q37718542 | trans-Resveratrol as a neuroprotectant. |
Search more.